Acasti Pharma Reports Third Quarter 2023 Operational Results

3 years ago

Company to Host Conference Call Today at 1:00pm ET LAVAL, Québec, Feb. 14, 2023 (GLOBE NEWSWIRE) -- Acasti Pharma Inc.…

Amicus Therapeutics to Announce Full-Year 2022 Financial Results on March 1, 2023

3 years ago

PHILADELPHIA, Feb. 14, 2023 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that the Company will host a conference…

TELA Bio Awarded Biosynthetic Mesh Products Agreement with a National Group Purchasing Organization

3 years ago

MALVERN, Pa., Feb. 14, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on…

G Medical Innovations announces receipt of patent from USPTO for vital signs sensors

3 years ago

Rehovot, Israel, Feb. 13, 2023 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (Nasdaq: GMVD) (the “Company” or “G Medical…

Entera Bio to Participate in the SVB Securities Global Biopharma Conference

3 years ago

JERUSALEM, Feb. 13, 2023 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a late-clinical stage, leader…

Hyperfine, Inc. Announces FDA Clearance for Improved AI-Powered Software and Expanded Field of View for the Swoop® Portable MR Imaging® System

3 years ago

Latest Swoop® software improves image quality for DWI imaging of the brainGUILFORD, Conn., Feb. 13, 2023 (GLOBE NEWSWIRE) -- Hyperfine,…

Cannabix Technologies to Test Contactless Alcohol Breathalyzer (CAB) in Montana

3 years ago

Cannabix has developed a contactless alcohol breathalyzer for employers and vehicles Cannabix Contactless Alcohol Breathalyzer Contactless Alcohol Breathalyzer for workplace…

NurExone Biologic Inc. Emerges as a Promising Investment Opportunity in Biotechnology

3 years ago

TORONTO and TEL AVIV, Israel, Feb. 13, 2023 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (FSE: J90) (NRX.V), a…

Acer Therapeutics Announces Full Enrollment of Phase 2a Trial of ACER-801 (Osanetant) for Treatment of Moderate to Severe Vasomotor Symptoms Associated with Menopause

3 years ago

Topline trial results expected mid-March 2023NEWTON, Mass., Feb. 13, 2023 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical…

Anika Announces First Surgeries Performed Using the New RevoMotion™ Reverse Shoulder Arthroplasty System and Commences Limited Market Release in the United States

3 years ago

RevoMotion significantly expands Anika’s shoulder arthroplasty portfolio and provides a new solution in the over $800 million U.S. reverse shoulder…